gemfibrozil has been researched along with Adolescent Obesity in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Of all the medications currently available, the fibric acid derivatives have a cholesterol lowering profile that is most likely to be effective in obese children with the high TG/low HDL phenotype and data from a recently published study of gemfibrozil in children with metabolic syndrome are promising." | 4.89 | Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents. ( Jellerson, KD; Kennedy, MJ; Snow, MZ; Zacchetti, ML, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kennedy, MJ | 1 |
| Jellerson, KD | 1 |
| Snow, MZ | 1 |
| Zacchetti, ML | 1 |
1 review available for gemfibrozil and Adolescent Obesity
| Article | Year |
|---|---|
Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents.
Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Fibri | 2013 |